The Efficacy of Topical Serum X for Skin Brightening

NCT ID: NCT05693948

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted to evaluate the effectiveness of topical serum X containing arbutin and glutathione for skin brightening. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 4, 8 and week 12.The main questions this study aims to answer are:

1. The skin brightening effect of the product on facial skin.
2. To observe any adverse effect occurrence with the usage of the product.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Serum X

Participants will used serum X twice daily for 12 weeks

Group Type EXPERIMENTAL

Other: Serum X

Intervention Type OTHER

Serum X contain arbutin and glutathione

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Other: Serum X

Serum X contain arbutin and glutathione

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Malaysia citizen
* Male and female (age 18-30 years old)

Exclusion Criteria

* Participant with severe acne skin condition
* Participant who is taking isotretinoin, immunocompromised patients and received laser and light treatment within the last three months
* Participant who undergo whitening or cosmetic treatments such as botox and dermal fillers within the previous six month
* Participant with a history of facial surgery such as facelift or nose reshaping
* Participant with history of allergies to any ingredient in the study product
* Participant who is pregnant or plan to get pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Petaling Jaya, Selangor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UMRAMREC001-22

Identifier Type: -

Identifier Source: org_study_id